InvestorsHub Logo
Post# of 316255
Next 10
Followers 362
Posts 113703
Boards Moderated 5
Alias Born 12/28/2000

Re: None

Thursday, 06/02/2022 10:17:38 AM

Thursday, June 02, 2022 10:17:38 AM

Post# of 316255
IMUX down 42% - nice bounce from opening price (I missed that) - Phase 2 study of vidofludimus calcium, its lead asset, missed the primary endpoint in patients with moderate-to-severe ulcerative colitis

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.